07 June 2020
Visiongain has launched a new pharma report Controlled Release Drug Delivery Market Report 2020-2030: Forecasts by Release Mechanism (Activation-modulated Drug Delivery Systems (Hydrodynamic Pressure Activated, Magnetically Activated, Mechanically Activated, Osmotic Pressure Activated, Vapor Pressure Activated), Chemically Activated (Enzyme Activated, Hydrolysis Activated, pH Activated), Feedback Regulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Polymer Based Systems), Technology (Coacervation, Implants, Micro Encapsulation, Targeted Delivery, Transdermal, Wurster Technique, Others), Application (Drug Eluting Stents, Infusion Pumps, Injectable, Metered Dose Inhalers, Oral Controlled-drug delivery Systems, Transdermal and Ocular Patches), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).
The global controlled release drug delivery market is anticipated to grow at a lucrative CAGR of ~xyz% and anticipated to reach USD xyz billion by 2020. Visiongain anticipates that changing prescription pattern and growing demand from physicians for controlled release systems over the conventional drug delivery systems is projected to fuel market growth
Constantly growing R&D investment by pharmaceutical manufacturers to improve effective medication for chronic and non-communicable diseases such as cancer, diabetes, and hypertension is anticipated to fuel demand development. For example, Taris, a biomedical company-based R&D pipeline product TAR-200 (Gemcitabine) indicated for the treatment of bladder cancer, includes a controlled release drug delivery system. Additionally, the market growth is attributed to the aging population as this patient pool cannot tolerate high doses of drugs owing to severe side effects, thus fueling the demand for controlled release drug delivery systems.
The controlled release drugs improve efficacy, patient compliance, and drug effect on the body. Additionally, controlled drug delivery help in achieving long-term therapeutic effects as compared to the traditional delivery systems. As a result of these advantages, the global controlled drug delivery market is anticipated to flourish over the forecast period.
North America holds the majority of the market share and will continue to dominate in the future as a result of several research projects in the region, coupled with funding for research institutes from the government. Also, the market will continue to be driven by the existence of the target population and increased R&D investment by important business organizations. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to the growing pharmaceutical industry across the markets such as India and China. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost the controlled release drug delivery market growth over the forecast period.
Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the controlled release drug delivery market.
The comprehensive market report features companies such as Alkermes plc, Aradigm Corporation, Capsugel, Coating Place, Inc., Corium International, Inc., Depomed, Inc., HELENA CHEMICAL, ICL, JCAM AGRI., Johnson and Johnson Services, Inc., KINGENTA, KOCH INDUSTRIES, Merck and Co.,Inc., MOSAIC COMPANY, NUFARM LTD., NUTRIEN, LTD., Orbis Biosciences, Inc., Pfizer, Inc., SCOTTSMIRACLE-GRO, YARA INTERNATIONAL ASA among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.
18 January 2022
The desire for various types of medications to assist combat a growing number of chronic diseases & lifestyle-related ailments is fuelling the overall deep freeze packaging logistics market demand.
14 January 2022
With COVID-19 pandemic, the prefilled syringes business has witnessed a significant growth. Since the outbreak of the pandemic, global market players involved in the development of the prefilled syringes market across the globe have increased their investment in raw materials and resources owing to the rise in demand for home based healthcare services.
11 January 2022
To promote their organic revenue growth and market presence, the top companies are pursuing different strategic initiatives such as OEM collaborations and new product development with better technological intricacy.